Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,061 | 30,797 | 36,842 | 41,713 | 10,467 |
| TOTAL | $29,402 | $34,746 | $39,572 | $43,273 | $11,388 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $29,402 | $34,746 | $39,572 | $43,273 | $11,388 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,483 | 2,187 | 2,088 | 1,812 | 2,780 |
| TOTAL | $2,483 | $2,187 | $2,088 | $1,812 | $2,830 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 0 | 1,022 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $1,022 |
| Total Liabilities | $2,483 | $2,187 | $2,088 | $1,812 | $3,852 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47 | 47 | 47 | 47 | 20 |
| Retained earnings | -33,726 | -27,841 | -22,704 | -18,586 | -15,371 |
| TOTAL | $26,919 | $32,559 | $37,485 | $41,461 | $7,536 |
| Total Liabilities And Equity | $29,403 | $34,746 | $39,573 | $43,273 | $11,388 |